Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $51.2500 (13.89%) ($46.2500 - $51.2500) on Fri. Apr. 12, 2013. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 12.39% (three month average) | RSI | 53 | Latest Price | $51.2500(13.89%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR advances 1% a day on average for past five trading days. | Weekly Trend | CAPR advances 0.5% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) PEJ(5%) IWM(4%) EWP(3%) XAR(3%) XLY(3%) | Factors Impacting CAPR price | CAPR will decline at least -6.195% in a week (0% probabilities). IGOV(-2%) EMHY(-2%) REMX(-1%) GLD(-1%) EWY(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -6.195% (StdDev 12.39%) | Hourly BBV | 0 () | Intraday Trend | 10.8% | | | |
|
5 Day Moving Average | $49.45(3.64%) | 10 Day Moving Average | $48.83(4.96%) | 20 Day Moving Average | $48.57(5.52%) | To recent high | -44.6% | To recent low | 33.1% | Market Cap | $1.01b | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |